.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
Covington
Cerilliant
McKinsey
Citi
Harvard Business School
Cipla
Deloitte
Julphar

Generated: December 12, 2017

DrugPatentWatch Database Preview

Kv Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for KV PHARM, and what generic and branded alternatives to KV PHARM drugs are available?

KV PHARM has forty-eight approved drugs.



Summary for Kv Pharm

US Patents:0
Tradenames:26
Ingredients:26
NDAs:48
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Kv PharmBROMPHENIRAMINE MALEATEbrompheniramine maleateELIXIR;ORAL085466-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmCHLORPROMAZINE HYDROCHLORIDEchlorpromazine hydrochlorideTABLET;ORAL085750-002Jan 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmERGOLOID MESYLATESergoloid mesylatesTABLET;SUBLINGUAL085899-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmHYDROXYZINE HYDROCHLORIDEhydroxyzine hydrochlorideTABLET;ORAL087821-001Jun 23, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmTRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDESpseudoephedrine hydrochloride; triprolidine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL071798-001Mar 16, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmPREDNISONEprednisoneTABLET;ORAL084236-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmCHLORTHALIDONEchlorthalidoneTABLET;ORAL087311-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmERGOLOID MESYLATESergoloid mesylatesTABLET;SUBLINGUAL085900-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmACETIC ACIDacetic acid, glacialSOLUTION/DROPS;OTIC085493-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Kv PharmCHLORPROMAZINE HYDROCHLORIDEchlorpromazine hydrochlorideTABLET;ORAL085748-002Jan 4, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Kv Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Kv PharmMICRO-K LSpotassium chlorideFOR SUSPENSION, EXTENDED RELEASE;ORAL019561-003Aug 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
QuintilesIMS
Fuji
Dow
UBS
Daiichi Sankyo
Citi
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot